Published in Am J Psychiatry on July 01, 1997
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci (2011) 3.17
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull (2008) 2.81
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) (2003) 2.28
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr Res (2015) 2.14
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A (1998) 2.00
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest (2009) 1.87
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) (2003) 1.86
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology (2006) 1.80
A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci (2008) 1.51
Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb Cortex (2010) 1.30
Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast (2011) 1.29
Hippocampal neurons in schizophrenia. J Neural Transm (Vienna) (2002) 1.22
Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull (2011) 1.20
The chandelier neuron in schizophrenia. Dev Neurobiol (2011) 1.18
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry (2009) 1.17
Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry (2013) 1.11
Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophr Bull (2013) 1.09
Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. Cereb Cortex (2011) 1.07
Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clin Schizophr Relat Psychoses (2010) 1.06
Long-range synchrony of γ oscillations and auditory hallucination symptoms in schizophrenia. Int J Psychophysiol (2010) 1.05
Extracellular matrix abnormalities in schizophrenia. Neuropharmacology (2011) 1.04
Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res (2008) 1.03
Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model. Proc Natl Acad Sci U S A (2013) 1.01
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) (2011) 0.99
Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. Neurobiol Dis (2012) 0.97
Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale. Eur J Neurosci (2009) 0.96
Mapping Synaptic Pathology within Cerebral Cortical Circuits in Subjects with Schizophrenia. Front Hum Neurosci (2010) 0.96
Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience (2013) 0.95
Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. Curr Pharm Biotechnol (2012) 0.95
GABA abnormalities in schizophrenia: A methodological review of in vivo studies. Schizophr Res (2014) 0.93
Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia. Am J Psychiatry (2016) 0.93
Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia. J Neurogenet (2014) 0.92
Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia. Brain Struct Funct (2013) 0.90
Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia. Neuropsychopharmacology (2016) 0.89
Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. Dialogues Clin Neurosci (2009) 0.88
Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia. Schizophr Bull (2014) 0.88
A comparative perspective on minicolumns and inhibitory GABAergic interneurons in the neocortex. Front Neuroanat (2010) 0.87
Synchrony in schizophrenia: a window into circuit-level pathophysiology. Curr Opin Neurobiol (2014) 0.83
Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes. Neuropsychopharmacology (2015) 0.83
Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders. Mol Psychiatry (2014) 0.83
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. Curr Neuropharmacol (2005) 0.83
Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains. Psychiatry Res (2011) 0.82
Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala. Transl Psychiatry (2015) 0.82
Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophr Res (2014) 0.81
Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation. BMC Neurosci (2008) 0.79
Event-related potentials demonstrate deficits in acoustic segmentation in schizophrenia. Schizophr Res (2016) 0.78
Transcriptional dysregulation of γ-aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. Psychiatry Res (2014) 0.78
Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study. NPJ Schizophr (2015) 0.77
Ultrastructural Analysis of Parvalbumin Synapses in Human Dorsolateral Prefrontal Cortex. J Comp Neurol (2017) 0.75
Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. J Chem Neuroanat (2015) 0.75
A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia. Int J Mol Sci (2017) 0.75
Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia. Mol Psychiatry (2016) 0.75
Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei. Front Cell Neurosci (2015) 0.75
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry (2000) 6.91
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron (2000) 4.29
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry (2000) 3.44
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci (1987) 3.39
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91
Protoplasmic Streaming in Plants Sensitive and Insensitive to Chilling Temperatures. Science (1956) 2.85
Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry (1995) 2.73
Yeast sugar transporters. Crit Rev Biochem Mol Biol (1993) 2.43
Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol (1994) 2.25
The effect on blood-pressure of organ extracts. J Physiol (1911) 2.24
Fluorescent treponemal antibodies in fractionated syphilitic sera. The immunoglobulin class. Arch Dermatol (1969) 2.06
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A (1998) 2.00
Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2006) 1.99
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci (2001) 1.98
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry (2001) 1.94
Dendritic spine pathology in schizophrenia. Neuroscience (2012) 1.91
An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med (1995) 1.88
Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry (1999) 1.86
pepM is an essential gene in Salmonella typhimurium. J Bacteriol (1989) 1.85
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A (1996) 1.75
Summary of proceedings of the IUSTI Global Challenges Symposium (ISSTDR 2007/10th IUSTI World Congress). Int J STD AIDS (2009) 1.73
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71
A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol (2009) 1.67
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry (2010) 1.66
N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66
Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol (1995) 1.65
Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord (1983) 1.65
Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol (1991) 1.60
Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry (1999) 1.60
Effect of speaking rate on the perceptual structure of a phonetic category. Percept Psychophys (1989) 1.59
Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal. J Mol Biol (1999) 1.57
Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience (1995) 1.55
Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry (2001) 1.54
Articulation rate and its variability in spontaneous speech: a reanalysis and some implications. Phonetica (1984) 1.52
The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51
The TPI and FTA-ABS tests in treated late syphilis. JAMA (1968) 1.50
Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol (1992) 1.50
Experience with microaneurysm formation at the basilar terminus in the rabbit elastase aneurysm model. AJNR Am J Neuroradiol (2009) 1.50
A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Some effects of later-occurring information on the perception of stop consonant and semivowel. Percept Psychophys (1979) 1.47
Over the counter anti-infectives--of benefit to whom? J Antimicrob Chemother (1995) 1.46
Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45
Mupirocin-resistant MRSA. J Hosp Infect (1994) 1.45
Penile myiasis: a case report. Sex Transm Infect (2004) 1.44
Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.43
Amplification and purification of the bacteriophage Mu encoded B transposition protein. J Biol Chem (1985) 1.43
Epidurals redefined in analgesia and anesthesia: a distinction with a difference. J Obstet Gynecol Neonatal Nurs (1996) 1.42
The North American experience with photopheresis. Ther Apher (1999) 1.42
Interpretation of blood films in diagnosis of malaria. Lancet (1989) 1.41
Marrow aplasia and sulindac. Ann Intern Med (1980) 1.40
GnRH agonists: gonadorelin, leuprolide and nafarelin. Am Fam Physician (1991) 1.40
GFPcre fusion vectors with enhanced expression. Anal Biochem (1999) 1.39
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39
The management of lead exposure in pediatric populations. Nurse Pract (1990) 1.38
Finasteride for benign prostatic hyperplasia. Am Fam Physician (1992) 1.38
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-beta2-glycoprotein-1 ELISAs. J Thromb Haemost (2006) 1.38
Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry (1990) 1.36
Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex (2004) 1.36
Anti-inflammatory actions of dapsone and its related biochemistry. J Pharm Pharmacol (1976) 1.36
Retrospective audit of the efficacy and safety of the combined intranasal/intravenous midazolam sedation technique for the dental treatment of adults with learning disability. Br Dent J (2008) 1.35
Phonetic prototypes: influence of place of articulation and speaking rate on the internal structure of voicing categories. J Acoust Soc Am (1992) 1.35
Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J Comp Neurol (1996) 1.35
Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J Comp Neurol (1993) 1.34
Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. J Neurophysiol (2000) 1.32
Prospective study of postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry (1991) 1.31
Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res (1999) 1.31
Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. Neuroscience (2005) 1.30
Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry (2006) 1.30
Primary structure of phage mu transposase: homology to mu repressor. Proc Natl Acad Sci U S A (1985) 1.30
The hierarchical development of monkey visual cortical regions as revealed by the maturation of parvalbumin-immunoreactive neurons. Brain Res Dev Brain Res (1996) 1.30
Management of clusters of meningococcal disease. PHIS Meningococcus Working Group and Public Health Medicine Environmental Group. Commun Dis Rep CDR Rev (1997) 1.30
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30
The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci (1987) 1.29
Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res (1995) 1.28
Horizontal synaptic connections in monkey prefrontal cortex: an in vitro electrophysiological study. Cereb Cortex (2000) 1.26
Treated late syphilis: immunoglobulin class of antibodies reactive with Treponema pallidum. J Invest Dermatol (1969) 1.24
Properties of excitatory synaptic responses in fast-spiking interneurons and pyramidal cells from monkey and rat prefrontal cortex. Cereb Cortex (2005) 1.23
Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem (1997) 1.23
Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol (1995) 1.22
Cloning and characterization of an AAC(6') gene from Serratia marcescens. J Antimicrob Chemother (1988) 1.22
Erosive arthritis associated with apatite crystal deposition. Arthritis Rheum (1981) 1.22
Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: a tyrosine hydroxylase immunohistochemical study. Biol Psychiatry (1994) 1.21
Lysosomal enzyme levels in the blood of arthritic rats. Biochem Pharmacol (1971) 1.21
Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood (1982) 1.20
Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry (1997) 1.20
Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience (1997) 1.20
WHO global strategy for the prevention and control of sexually transmitted infections: time for action. Sex Transm Infect (2007) 1.19
Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet J (2007) 1.19
Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol (2001) 1.18
Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res (1996) 1.17
Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation (2000) 1.16
Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun (2005) 1.16
Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res (2001) 1.15
Gene therapy for human hemoglobinopathies. Proc Soc Exp Biol Med (1993) 1.15
Interconversion of metarhodopsins I and II: a branched photointermediate decay model. Biochemistry (1990) 1.14
Balloon-assisted coiling of intracranial aneurysms: evaluation of local thrombus formation and symptomatic thromboembolic complications. AJNR Am J Neuroradiol (2007) 1.13